VIRP Virbac SA

MAR Rapport Hebdomadaire_VIRBAC SA_30 octobre au 3 novembre 2023

MAR Rapport Hebdomadaire_VIRBAC SA_30 octobre au 3 novembre 2023





Déclaration des transactions sur actions propres réalisées du 2023-10-30 au 2023-11-03BNP PARIBAS
           
Présentation agrégée par jour et par marché          
           
Nom de l'émetteurCode Identifiant de l'émetteurJour de la transactionCode identifiant de l’instrument financierVolume total journalier (en nombre d’actions)Prix pondéré moyen journalier d’acquisition des actions *Marché (MIC Code)      
VIRBAC969500QQ1X5XHG64964410/30/2023FR00000315777270.0000AQEU     
VIRBAC969500QQ1X5XHG64964410/30/2023FR00000315771270.0000TQEX     
VIRBAC969500QQ1X5XHG64964410/31/2023FR0000031577294270.0000XPAR     
VIRBAC969500QQ1X5XHG64964411/1/2023FR000003157781270.0000AQEU     
VIRBAC969500QQ1X5XHG64964411/1/2023FR000003157775269.8467CEUX     
VIRBAC969500QQ1X5XHG64964411/1/2023FR000003157737270.0000TQEX     
VIRBAC969500QQ1X5XHG64964411/1/2023FR0000031577397269.9622XPAR     
* Arrondi à quatre chiffres après la virguleTOTAL892269.9703      
           
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
Détail transaction par transaction          
           
Nom de l'émetteurCode Identifiant de l'émetteurNom du PSICode identifiant du PSIJour/heure de la transaction (CET)Code identifiant de l’instrument financierPrix UnitaireDeviseQuantité achetéeCode identifiant marchéNuméro de référence de la transactionObjectif du rachat
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4830/10/2023 17:29:46FR0000031577270.00EUR1TQEX2023103012010898 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4830/10/2023 17:29:49FR0000031577270.00EUR7AQEU2023103012010950 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4831/10/2023 12:11:02FR0000031577270.00EUR261XPAR2023103112331255 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4831/10/2023 12:11:02FR0000031577270.00EUR24XPAR2023103112331257 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4831/10/2023 12:11:02FR0000031577270.00EUR9XPAR2023103112331259 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:18:45FR0000031577270.00EUR10CEUX2023110112497003 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:18:45FR0000031577270.00EUR2CEUX2023110112497005 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:18:45FR0000031577270.00EUR2CEUX2023110112497007 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:18:45FR0000031577270.00EUR297XPAR2023110112497009 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:18:45FR0000031577270.00EUR14XPAR2023110112497011 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:36:35FR0000031577270.00EUR14AQEU2023110112501790 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:36:35FR0000031577270.00EUR17AQEU2023110112501792 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:36:35FR0000031577270.00EUR4AQEU2023110112501794 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:37:38FR0000031577269.50EUR10XPAR2023110112502040 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:37:38FR0000031577269.50EUR13XPAR2023110112502042 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:37:38FR0000031577269.50EUR7XPAR2023110112502044 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:52:04FR0000031577270.00EUR1TQEX2023110112507552 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:52:04FR0000031577270.00EUR6TQEX2023110112507554 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:52:04FR0000031577270.00EUR7TQEX2023110112507556 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:52:04FR0000031577270.00EUR9XPAR2023110112507558 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:52:04FR0000031577270.00EUR5XPAR2023110112507560 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:52:04FR0000031577270.00EUR5XPAR2023110112507562 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:52:04FR0000031577270.00EUR8XPAR2023110112507564 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:52:06FR0000031577270.00EUR7XPAR2023110112507568 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 11:53:50FR0000031577270.00EUR1AQEU2023110112507896 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 13:00:50FR0000031577270.00EUR17CEUX2023110112524060 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 13:00:50FR0000031577270.00EUR7CEUX2023110112524062 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 13:00:50FR0000031577270.00EUR9TQEX2023110112524064 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 13:00:50FR0000031577270.00EUR9TQEX2023110112524066 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 13:00:50FR0000031577270.00EUR5TQEX2023110112524068 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 13:00:50FR0000031577270.00EUR24AQEU2023110112524070 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 13:00:50FR0000031577270.00EUR4XPAR2023110112524072 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 13:00:50FR0000031577270.00EUR18XPAR2023110112524074 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 13:24:56FR0000031577269.50EUR23CEUX2023110112529911 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 17:16:54FR0000031577270.00EUR21AQEU2023110112626117 
VIRBAC969500QQ1X5XHG649644BNP Paribas SA6EWKU0FGVX5QQJHFGT4801/11/2023 17:16:54FR0000031577270.00EUR14CEUX2023110112626119 



Pièce jointe



EN
06/11/2023

Underlying

VIRPVirbac SA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Virbac SA

Anthony Dick ... (+3)
  • Anthony Dick
  • Marc Lavaud
  • Michael Foundoukidis
CON CONTINENTAL AKTIENGESELLSCHAFT
BMW BAYERISCHE MOTOREN WERKE AKTIENGESELLSCHAFT
TKA THYSSENKRUPP AG
MT ARCELORMITTAL SA
RNO RENAULT SA
APAML APERAM SA
VOLV B VOLVO AB CLASS B
OUT1V OUTOKUMPU OYJ
EO FAURECIA SA
SSAB A SSAB AB CLASS A
DAI DAIMLER AG
POM PLASTIC OMNIUM SE
SZG SALZGITTER AG
TYRES NOKIAN RENKAAT OYJ
KCO KLOECKNER & CO SE
VIRP VIRBAC SA
JCQ JACQUET METALS SA
VOE VOESTALPINE AG
ACX ACERINOX SA
FR VALEO SE
VOW3 VOLKSWAGEN AG PREF
CIE CIE AUTOMOTIVE S.A.
RACE FERRARI NV
PSG PROSEGUR COMPANIA DE SEGURIDAD SA
PIRC PIRELLI & C. S.P.A.
GEST GESTAMP AUTOMOCION S.A.
8TRA TRATON SE
AML ASTON MARTIN LAGONDA GLOBAL HOLDINGS
STLA STELLANTIS N.V.
DTG DAIMLER TRUCK
IVG IVECO GROUP
ML COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN
P911 DR. ING. H.C. F. PORSCHE AKTIENGESELLSCHAFT
NCH2 THYSSENKRUPP NUCERA AG & CO.
ALIV SDB AUTOLIV INC.
BRE BREMBO S.P.A.
12/17/25 December 17, 2025 1 FR
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
12/17/25 December 17, 2025 1 EN
Christophe-Raphaël Ganet
  • Christophe-Raphaël Ganet
12/17/25 December 17, 2025 1 FR
 PRESS RELEASE
Free
VIRP VIRBAC SA

VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm

VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm Acquisition provides Virbac with a leading specialty product, in a growing segment, to improve the quality of life for senior cats.We are delighted to announce the acquisition of an innovative drug from Norbrook to stabilize feline hyperthyroidism. Virbac will ensure the direct distribution of this treatment under the Thyronorm brand in the United Kingdom, Australia, and New Zealand, and under the Felanorm brand in the United States. In Europe, distribution will continue to be managed by Boehringer Ingelheim and Elanco (in Germany) b...

December 16, 2025 1 EN
 PRESS RELEASE
Free
VIRP VIRBAC SA

VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm

VIRBAC: Hyperthyroïdie féline : Virbac acquiert Thyronorm Cette acquisition apporte à Virbac un produit de spécialité de premier plan, sur un segment en croissance, pour améliorer la qualité de vie des chats âgés.Nous sommes ravis d'annoncer l'acquisition auprès de Norbrook d’un médicament innovant pour stabiliser l'hyperthyroïdie féline. Virbac assurera la distribution directe de ce traitement sous la marque Thyronorm au Royaume-Uni, en Australie et Nouvelle-Zélande ainsi qu’aux États-Unis sous la marque Felanorm,. En Europe, la distribution restera gérée par Boehringer Ingelheim et Elanco...

December 16, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch